In a series of tweets after the Drugs Controller General of India (DCGI) approved Oxford's vaccine Covishield and Bharat Biotech's Covaxin for restricted emergency use, Modi said it will make every Indian proud that both the vaccines are made in India.
The COVID-19 active caseload remained below 3 lakh for the seventh consecutive day.
Minister for Health and Family Welfare Anbumani Ramadoss is on an official visit to China,
The recoveries have mounted to 11,45,629, while there are 5,67,730 active cases of coronavirus infection in the country presently.
The number of active COVID-19 cases stands at 2,15,125, while 3,34,821 patients have been cured/discharged.
The Rhesus macaque monkeys, used worldwide in medical research, are believed to be the best non-human primates for such studies.
The COVID-19 case fatality rate has further declined to 1.47 per cent.
This is also the highest daily rise in the last 83 days. As many as 26,624 new infections were recorded on December 20.
India's COVID-19 tally rose to 1,12,62,707 with 17,921 fresh cases being reported in a day, while the recoveries surpassed 1.09 crore, the Union Health Ministry said on Wednesday.
A 39-year-old man tested positive for the Nipah virus, which was transmitted to him through direct contact with an infected person who died on August 30, State Health Minister Veena George said in Kozhikode on Friday.
Ms Swaraj was a conscientious woman who understood suffering and pathos and attempted in her inimitable way to mitigate them, recalls Rup Narayan Das.
The total coronavirus cases mounted to 40,23,179, while the death toll climbed to 69,561 with 1,089 people succumbing to the disease in a span of 24 hours, data updated at 8 am showed.
With 1,209 new deaths reported across the country, the toll due to the disease stands at 76,271.
There are 8,97,394 active cases of COVID-19, which is 20.53 per cent of the total caseload in the country, the data stated.
The COVID-19 case fatality rate due to the coronavirus infection stands at 1.7 per cent.
The doctors treating SARS suspects or patients will use the Defence Research Development Organisation made Nuclear-Biological-Chemical weapon masks.
The trial in India is part of a multi-country initiative of the same vaccine candidate. Trials are already on in Germany and Belgium and initial results have given excellent safety data.
The number of people who have recuperated from the disease surged to 98,34,141 pushing the national recovery rate to 95.99 per cent, while the COVID-19 case fatality rate stands at 1.45 per cent.
The increase in the numbers is reasoned to the absence of a regulatory or monitoring agency, official sources said.
The COVID-19 case fatality rate has declined to 1.84 per cent.
The number of people who have recuperated from the disease surged to 97,17,834, pushing the national recovery rate to 95.77 per cent, while the COVID-19 case fatality rate stands at 1.45 per cent.
The total cases of coronavirus infections mounted to 29,05,823, while the death toll climbed to 54,849 with 983 new fatalities being reported in a span of 24 hours, the data updated at 8 am showed.
The death toll climbed to 5,24,413 with 65 fresh fatalities.
India has been reporting over 60,000 cases daily since August 7, barring August 11 when the country registered 53,601 new instances of the infection.
India's COVID-19 caseload surpassed the somber one-crore mark Saturday, adding 10 lakh cases in nearly a month, while the total number of recoveries surged to 95.50 lakh, according to the Union health ministry data.
India saw 81,466 new coronavirus infections being reported in a span of 24 hours, the highest single-day rise in six months, taking the COVID-19 tally of cases to 1,23,03,131, according to the Union health ministry data updated on Friday.
The ICMR on Monday asked states and union territories to stop using the test kits procured from the Chinese companies -- Guangzhou Wondfo Biotech and Zhuhai Livzon Diagnostics -- due to "wide variations" in their performance.
This is the seventh consecutive day that COVID-19 cases have increased by more than 50,000.
With this latest spike, the total cases in the country stand at 16,38,871.
The recovery rate among COVID-19 patients was recorded at 64.44 per cent, while the fatality rate was at 2.21 per cent.
A total of 25,12,388 samples have been tested for coronavirus infection as on 9 am, May 20 all over the country.
The national recovery rate is 93.94 per cent while the COVID-19 case fatality rate stands at 1.45 per cent.
According to the Indian Council of Medical Research, 22,82,80,763 samples have been tested up to March 15, with 8,73,350 samples tested on Monday
India's COVID-19 tally had crossed the 20-lakh mark on August 7, 30 lakh on August 23 and 40 lakh on September 5. It went past 50 lakh on September 16, 60 lakh on September 28, 70 lakh on October 11 and crossed 80 lakh on October 29.
The active cases comprise 0.04 per cent of the total infections, while the national COVID-19 recovery rate was recorded as 98.74 per cent, the ministry said.
The active cases constituted 0.04 per cent of the total infections, while the national recovery rate was recorded at 98.74 per cent, the health ministry said.
"The COVID-19 cases are rising, but hospitalization and deaths are still less," said sources.
India is currently using two vaccines for COVID-19 -- one developed by Oxford University and AstraZeneca and the other developed by Bharat Biotech in collaboration with the Indian Council of Medical Research-National Institute of Virology. Both the vaccines are being manufactured within the country by domestic firms.
Most of the pharma units are failing in documentation, and validation processes, and many don't have full-fledged quality control laboratories.
On the mathematical model which predicts 42,000 cases in the state by April end, the minister said, "The model is based on some scientific ground but it has taken the state's doubling rate of COVID-19 cases at 3.8.
